stoxline Quote Chart Rank Option Currency Glossary
  
Abpro Corporation (ABP)
0.99  -0.02 (-1.98%)    02-11 16:00
Open: 1.02
High: 1.0342
Volume: 56,564
  
Pre. Close: 1.01
Low: 0.96
Market Cap: 51(M)
Technical analysis
2025-02-11 4:42:58 PM
Short term     
Mid term     
Targets 6-month :  1.59 1-year :  1.92
Resists First :  1.36 Second :  1.64
Pivot price 1.09
Supports First :  0.9 Second :  0.74
MAs MA(5) :  1.01 MA(20) :  1.15
MA(100) :  5.57 MA(250) :  8.85
MACD MACD :  -0.3 Signal :  -0.4
%K %D K(14,3) :  22 D(3) :  25.2
RSI RSI(14): 35.9
52-week High :  13 Low :  0.9
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ABP ] has closed above bottom band by 30.0%. Bollinger Bands are 81% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 14 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.03 - 1.04 1.04 - 1.04
Low: 0.95 - 0.95 0.95 - 0.96
Close: 0.98 - 0.99 0.99 - 1
Company Description

Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers; and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic partnership with Abpro Bio Co. Ltd and NJCTTQ. The company was formerly known as Abpro Corporation and changed its name to Abpro Holdings, Inc. in November 2024. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.

Headline News

Tue, 14 Jan 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Thu, 12 Dec 2024
Abpro Holdings Debuts on Nasdaq with $60M+ Funding Package to Advance Cancer Therapy Pipeline - StockTitan

Fri, 06 Dec 2024
Abpro Holdings Inc Rings the Closing Bell - Nasdaq

Tue, 26 Nov 2024
Abpro Holdings Merges with ACAB, Trades on Nasdaq - TipRanks

Wed, 13 Nov 2024
Abpro Announces Closing of Business Combination with Atlantic Coastal Acquisition Corp. II - PR Newswire

Fri, 22 Sep 2023
Antibody biotech Abpro taps SPAC to get back on Nasdaq track 5 years after axed IPO - Fierce Biotech

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 0 (M)
Shares Float 52 (M)
Held by Insiders 0 (%)
Held by Institutions 58.5 (%)
Shares Short 6 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -1.131e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -15 %
Return on Assets (ttm) 975 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 72000 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth -0.4 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -8 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow -0
Stock Dividends
Dividend 0
Forward Dividend 209200
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android